Nova Historical Balance Sheet

EYE Stock   0.10  0.01  9.09%   
Trend analysis of Nova Eye Medical balance sheet accounts such as Other Current Liabilities of 2.7 M or Total Current Liabilities of 9.4 M provides information on Nova Eye's total assets, liabilities, and equity, which is the actual value of Nova Eye Medical to its prevalent stockholders. By breaking down trends over time using Nova Eye balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Nova Eye Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nova Eye Medical is a good buy for the upcoming year.

Nova Eye Inventory

9.02 Million

  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Nova Eye Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Nova Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Nova Eye Medical at a specified time, usually calculated after every quarter, six months, or one year. Nova Eye Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nova Eye and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nova currently owns. An asset can also be divided into two categories, current and non-current.

Nova Eye Balance Sheet Chart

At this time, Nova Eye's Common Stock Shares Outstanding is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 40.5 M in 2025, whereas Net Debt is likely to drop (2.6 M) in 2025.

Total Assets

Total assets refers to the total amount of Nova Eye assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nova Eye Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.
Most accounts from Nova Eye's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nova Eye Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Nova Eye Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Nova Eye's Common Stock Shares Outstanding is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 40.5 M in 2025, whereas Net Debt is likely to drop (2.6 M) in 2025.
 2022 2023 2024 2025 (projected)
Short and Long Term Debt Total1.5M3.3M3.9M6.8M
Total Assets30.4M29.9M34.4M40.5M

Nova Eye balance sheet Correlations

0.70.530.830.980.630.83-0.480.620.480.640.28-0.460.640.640.21-0.270.270.64-0.390.840.730.950.670.82-0.02
0.70.790.920.550.920.310.240.20.42-0.040.28-0.23-0.040.880.03-0.280.340.950.30.930.880.480.920.53-0.06
0.530.790.720.370.690.180.330.230.16-0.170.05-0.25-0.170.86-0.18-0.410.360.830.40.810.710.320.670.320.01
0.830.920.720.70.790.50.040.380.640.160.13-0.40.160.9-0.01-0.350.090.930.120.980.860.660.940.63-0.08
0.980.550.370.70.510.89-0.650.660.410.780.3-0.450.780.470.27-0.210.260.47-0.570.710.610.990.530.820.0
0.630.920.690.790.510.320.210.130.29-0.010.49-0.18-0.010.740.1-0.190.520.830.280.820.860.430.820.58-0.1
0.830.310.180.50.890.32-0.750.610.250.840.09-0.310.840.260.1-0.20.170.26-0.620.50.340.910.320.73-0.3
-0.480.240.330.04-0.650.21-0.75-0.5-0.02-0.98-0.10.15-0.980.32-0.33-0.12-0.030.350.940.060.13-0.710.23-0.470.07
0.620.20.230.380.660.130.61-0.50.010.57-0.08-0.550.570.29-0.36-0.74-0.110.24-0.610.370.240.680.340.210.38
0.480.420.160.640.410.290.25-0.020.010.120.08-0.310.120.480.30.05-0.180.50.060.580.520.380.530.55-0.05
0.64-0.04-0.170.160.78-0.010.84-0.980.570.120.16-0.221.0-0.140.330.050.11-0.16-0.910.140.060.84-0.040.6-0.08
0.280.280.050.130.30.490.09-0.1-0.080.080.16-0.090.160.020.650.260.690.11-0.120.180.440.190.120.460.14
-0.46-0.23-0.25-0.4-0.45-0.18-0.310.15-0.55-0.31-0.22-0.09-0.22-0.24-0.020.470.22-0.310.23-0.38-0.51-0.38-0.41-0.28-0.54
0.64-0.04-0.170.160.78-0.010.84-0.980.570.121.00.16-0.22-0.140.330.050.11-0.16-0.910.140.060.84-0.040.6-0.08
0.640.880.860.90.470.740.260.320.290.48-0.140.02-0.24-0.14-0.23-0.470.160.970.380.930.750.420.850.39-0.05
0.210.03-0.18-0.010.270.10.1-0.33-0.360.30.330.65-0.020.33-0.230.760.41-0.15-0.260.010.240.21-0.140.520.02
-0.27-0.28-0.41-0.35-0.21-0.19-0.2-0.12-0.740.050.050.260.470.05-0.470.760.16-0.420.0-0.36-0.2-0.21-0.440.13-0.36
0.270.340.360.090.260.520.17-0.03-0.11-0.180.110.690.220.110.160.410.160.180.030.230.350.190.030.44-0.04
0.640.950.830.930.470.830.260.350.240.5-0.160.11-0.31-0.160.97-0.15-0.420.180.410.950.840.40.920.43-0.04
-0.390.30.40.12-0.570.28-0.620.94-0.610.06-0.91-0.120.23-0.910.38-0.260.00.030.410.140.15-0.620.25-0.3-0.17
0.840.930.810.980.710.820.50.060.370.580.140.18-0.380.140.930.01-0.360.230.950.140.880.660.90.66-0.06
0.730.880.710.860.610.860.340.130.240.520.060.44-0.510.060.750.24-0.20.350.840.150.880.510.850.670.14
0.950.480.320.660.990.430.91-0.710.680.380.840.19-0.380.840.420.21-0.210.190.4-0.620.660.510.470.78-0.06
0.670.920.670.940.530.820.320.230.340.53-0.040.12-0.41-0.040.85-0.14-0.440.030.920.250.90.850.470.480.01
0.820.530.320.630.820.580.73-0.470.210.550.60.46-0.280.60.390.520.130.440.43-0.30.660.670.780.48-0.21
-0.02-0.060.01-0.080.0-0.1-0.30.070.38-0.05-0.080.14-0.54-0.08-0.050.02-0.36-0.04-0.04-0.17-0.060.14-0.060.01-0.21
Click cells to compare fundamentals

Nova Eye Account Relationship Matchups

Nova Eye balance sheet Accounts

202020212022202320242025 (projected)
Total Assets42.0M36.6M30.4M29.9M34.4M40.5M
Short Long Term Debt Total3.7M1.9M1.5M3.3M3.9M6.8M
Other Current Liab746K912K1.3M1.6M1.9M2.7M
Total Current Liabilities4.7M3.9M6.3M5.7M6.5M9.4M
Total Stockholder Equity35.3M30.4M23.2M21.3M24.5M29.1M
Property Plant And Equipment Net3.5M2.9M2.4M3.9M4.5M4.4M
Current Deferred Revenue8.2M(1.9M)1.0(639K)(734.9K)(698.1K)
Net Debt(14.1M)(6.1M)(5.9M)(2.8M)(2.5M)(2.6M)
Retained Earnings892K(6.6M)(21.9M)(30.7M)(35.3M)(33.5M)
Accounts Payable2.0M2.4M4.3M3.6M4.1M2.8M
Cash17.8M8M7.4M6.2M7.1M6.6M
Non Current Assets Total15.7M21.0M15.8M15.1M17.4M13.4M
Non Currrent Assets Other(6.9M)(10.1M)(10.8M)4.2M3.8M4.0M
Cash And Short Term Investments17.8M8M7.4M6.2M7.1M6.6M
Net Receivables1.9M2.0M1.9M4.1M4.7M6.4M
Common Stock Shares Outstanding147.5M148.5M160.2M204.1M234.8M246.5M
Liabilities And Stockholders Equity42.0M36.6M30.4M29.9M34.4M40.5M
Non Current Liabilities Total2.0M2.4M892K2.9M3.3M2.1M
Inventory2.9M3.5M3.8M4.3M4.9M9.0M
Other Stockholder Equity(102.9M)(37.6M)(30.8M)(1.0)(0.9)(0.94)
Total Liab6.7M6.2M7.2M8.6M9.8M11.4M
Property Plant And Equipment Gross13.1M15.2M9.2M10.4M11.9M8.7M
Total Current Assets26.3M15.6M14.6M14.7M17.0M22.8M
Accumulated Other Comprehensive Income(2.2M)(439K)(87.0K)(693K)(623.7K)(592.5K)
Short Term Debt1.9M544K639K480K552K524.4K
Common Stock36.7M37.4M45.2M52.7M60.6M33.6M
Other Current Assets3.7M2.0M1.4M234K269.1K255.6K
Intangible Assets12.1M18.0M13.3M7.0M8.1M6.8M
Other Assets7.6M8.7M10.9M4.9M4.4M4.2M
Long Term Debt Total1.4M1.8M1.4M892K802.8K1.3M
Property Plant Equipment2.9M3.5M2.9M2.4M2.1M2.0M
Other Liab1.7M365K212K966K869.4K1.0M
Net Tangible Assets97.2M31.9M23.2M14.7M13.3M12.6M
Deferred Long Term Liab7.5M8.7M10.9M4.9M4.4M8.7M
Capital Lease Obligations2.3M1.9M1.5M3.3M3.9M4.0M
Net Invested Capital36.8M30.4M23.2M21.3M19.2M18.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nova Stock Analysis

When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.